Drug Maker Will Study ADHD Medication in Preschool Children

The manufacturer of the attention deficit hyperactivity disorder (ADHD) drug Vyvanse has agreed to study the drug in preschool children, at the request of the U.S. Food and Drug Administration (FDA).

The company, Shire, also makes the ADHD drug Adderall, the only such drug approved to treat children under age 6 in the United States.

A government study published last month found more than 10,000 toddlers in the United States are receiving medication for ADHD outside established guidelines. The report found children covered by Medicaid are most likely to receive drugs such as Ritalin or Adderall.

Full story of ADHD medication in children at drugfree.org

Published by

Will Savage

Quantum Units Continuing Education provides online CEU training's to licensed professional mental health therapists, counselors, social workers and nurses. Our blog provides updates in the field of news and research related to mental health and substance abuse treatment.